As of Feb 27
| +0.09 / +1.09%|
The 1 analysts offering 12-month price forecasts for GlycoMimetics Inc have a median target of 12.00, with a high estimate of 12.00 and a low estimate of 12.00. The median estimate represents a +44.23% increase from the last price of 8.32.
The current consensus among 1 polled investment analysts is to Buy stock in GlycoMimetics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.